Works matching DE "DOSE-response relationship in biochemistry"

Results: 4082
    1
    2
    3
    4
    5
    6

    Population pharmacokinetics and exposure–response relationship of the antituberculosis drug BTZ-043 Open Access.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 5, p. 1315, doi. 10.1093/jac/dkaf076
    By:
    • Koele, Simon E;
    • Heinrich, Norbert;
    • Jager, Veronique R De;
    • Dreisbach, Julia;
    • Phillips, Patrick P J;
    • Gross-Demel, Petra;
    • Dawson, Rodney;
    • Narunsky, Kim;
    • Wildner, Leticia M;
    • Mchugh, Timothy D;
    • Brake, Lindsey H M Te;
    • Diacon, Andreas H;
    • Aarnoutse, Rob E;
    • Hoelscher, Michael;
    • Svensson, Elin M
    Publication type:
    Article
    7
    8
    9
    10
    11

    Benchmark Response (BMR) Values for In Vivo Mutagenicity Endpoints.

    Published in:
    Environmental & Molecular Mutagenesis, 2025, v. 66, n. 4, p. 172, doi. 10.1002/em.70006
    By:
    • White, Paul A.;
    • Chen, Guangchao;
    • Chepelev, Nikolai;
    • Bell, Madison A.;
    • Gallant, Lauren R.;
    • Johnson, George E.;
    • Zeller, Andreas;
    • Beal, Marc A.;
    • Long, Alexandra S.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Impact of ISUP grade group on cancer-specific mortality in radical prostatectomy-treated prostate cancer patients with organ-confined disease.

    Published in:
    Canadian Urological Association Journal, 2025, v. 19, n. 5, p. 166, doi. 10.5489/cuaj.8941
    By:
    • Barletta, Francesco;
    • Tappero, Stefano;
    • Morra, Simone;
    • Incesu, Reha-Baris;
    • Garcia, Cristina Cano;
    • Piccinelli, Mattia Luca;
    • Scheipner, Lukas;
    • Tian, Zhe;
    • Gandaglia, Giorgio;
    • Stabile, Armando;
    • Mazzone, Elio;
    • Terrone, Carlo;
    • Longo, Nicola;
    • Tilki, Derya;
    • Chun, Felix K. H.;
    • de Cobelli, Ottavio;
    • Ahyai, Sascha;
    • Saad, Fred;
    • Shariat, Shahrokh F.;
    • Montorsi, Francesco
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 45, doi. 10.1007/s00280-008-0844-1
    By:
    • Attia, Steven;
    • Morgan-Meadows, Sherry;
    • Holen, Kyle D.;
    • Bailey, Howard H.;
    • Eickhoff, Jens C.;
    • Schelman, William R.;
    • Traynor, Anne M.;
    • Mulkerin, Daniel L.;
    • Campbell, Toby C.;
    • McFarland, Thomas A.;
    • Huie, Michael S.;
    • Cleary, James F.;
    • Tevaarwerk, Amye J.;
    • Alberti, Dona B.;
    • Wilding, George;
    • Liu, Glenn
    Publication type:
    Article
    38
    39
    40
    41
    42
    43

    Five-Year Update of an Expanded Phase II Study of Dose-Dense and -Intense Doxorubicin, Paclitaxel and Cyclophosphamide (ATC) in High-Risk Breast Cancer.

    Published in:
    Oncology, 2005, v. 69, n. 5, p. 372, doi. 10.1159/000089991
    By:
    • Abu-Khalaf, Maysa M.;
    • Windsor, Stephen;
    • Ebisu, Keita;
    • Salikooti, Saritha;
    • Ananthanarayanan, Gowri;
    • Chung, Gina G.;
    • DiGiovanna, Michael P.;
    • Haffty, Bruce G.;
    • Abrams, Martin;
    • Farber, Leonard R.;
    • Hsu, Arlene D.;
    • Reiss, Michael;
    • Zelterman, Daniel;
    • Burtness, Barbara A.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50